OBJECTIVE: To develop a juvenile mouse model to establish effects of in vivo hypothermia on expression of the inflammation-modulating cytokines tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and interleukin-10. Although induced hypothermia is neuroprotective in some patients, the mechanisms of protection are not well understood and concerns remain over potential detrimental effects, particularly in the setting of infection. We previously showed that in vitro hypothermia increases production of tumor necrosis factor-alpha and interleukin-1beta in lipopolysaccharide-treated monocytes. DESIGN: : Laboratory investigation. SETTING: Research laboratory. SUBJECTS: Juvenile (4-wk) male C57BL/6 mice. INTERVENTIONS: : Mice were given chlorpromazine to suspend thermoregulation and lipopolysaccharide to stimulate cytokine production. Core temperature was maintained at 32 degrees C or 37 degrees C for 6 hrs by adjusting environmental temperature. In separate experiments, lipopolysaccharide-treated mice were kept in a cooling chamber without chlorpromazine treatment. MEASUREMENTS AND MAIN RESULTS: Plasma and organs were collected for cytokine quantitation. Chlorpromazine-treated hypothermic mice had 2.3-fold and 1.8-fold higher plasma interleukin-6 and interleukin-10 levels at 6 hrs compared with identically treated normothermic mice (p < .05), whereas plasma tumor necrosis factor-alpha and interleukin-1beta were not significantly different at 2 hrs or 6 hrs. Liver tumor necrosis factor-alpha and interleukin-6 were significantly higher in hypothermic vs. normothermic mice, but lung and brain cytokines were not different. Lipopolysaccharide-treated mice kept in a cooling chamber without chlorpromazine treatment developed varying degrees of hypothermia with associated increases in plasma interleukin-6 and interleukin-10. A nonspecific marker of stress (plasma corticosterone) was not affected by hypothermia in lipopolysaccharide-treated mice. CONCLUSION: Further studies are necessary to determine the mechanism and physiologic consequences of augmented systemic interleukin-6 and interleukin-10 expression during induced hypothermia.
OBJECTIVE: To develop a juvenile mouse model to establish effects of in vivo hypothermia on expression of the inflammation-modulating cytokines tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and interleukin-10. Although induced hypothermia is neuroprotective in some patients, the mechanisms of protection are not well understood and concerns remain over potential detrimental effects, particularly in the setting of infection. We previously showed that in vitro hypothermia increases production of tumor necrosis factor-alpha and interleukin-1beta in lipopolysaccharide-treated monocytes. DESIGN: : Laboratory investigation. SETTING: Research laboratory. SUBJECTS: Juvenile (4-wk) male C57BL/6 mice. INTERVENTIONS: : Mice were given chlorpromazine to suspend thermoregulation and lipopolysaccharide to stimulate cytokine production. Core temperature was maintained at 32 degrees C or 37 degrees C for 6 hrs by adjusting environmental temperature. In separate experiments, lipopolysaccharide-treated mice were kept in a cooling chamber without chlorpromazine treatment. MEASUREMENTS AND MAIN RESULTS: Plasma and organs were collected for cytokine quantitation. Chlorpromazine-treated hypothermic mice had 2.3-fold and 1.8-fold higher plasma interleukin-6 and interleukin-10 levels at 6 hrs compared with identically treated normothermic mice (p < .05), whereas plasma tumor necrosis factor-alpha and interleukin-1beta were not significantly different at 2 hrs or 6 hrs. Liver tumor necrosis factor-alpha and interleukin-6 were significantly higher in hypothermic vs. normothermic mice, but lung and brain cytokines were not different. Lipopolysaccharide-treated mice kept in a cooling chamber without chlorpromazine treatment developed varying degrees of hypothermia with associated increases in plasma interleukin-6 and interleukin-10. A nonspecific marker of stress (plasma corticosterone) was not affected by hypothermia in lipopolysaccharide-treated mice. CONCLUSION: Further studies are necessary to determine the mechanism and physiologic consequences of augmented systemic interleukin-6 and interleukin-10 expression during induced hypothermia.
Authors: Marie Horan; Shingo Ichiba; Richard K Firmin; Hilliary M Killer; David Edwards; Denis Azzopardi; Rachel Hodge; Sailesh Kotecha; David Field Journal: J Pediatr Date: 2004-03 Impact factor: 4.406
Authors: Karen D Fairchild; Ishwar S Singh; Sandip Patel; Beth E Drysdale; Rose M Viscardi; Lisa Hester; Heather M Lazusky; Jeffrey D Hasday Journal: Am J Physiol Cell Physiol Date: 2004-04-07 Impact factor: 4.249
Authors: Alexander Torossian; Sebastian Ruehlmann; Martin Middeke; Daniel I Sessler; Wilfried Lorenz; Hinnerk F Wulf; Artur Bauhofer Journal: Crit Care Med Date: 2004-09 Impact factor: 7.598
Authors: L K Friedman; J Mancuso; A Patel; V Kudur; J R Leheste; S Iacobas; J Botta; D A Iacobas; D C Spray Journal: Eur J Neurosci Date: 2013-04-04 Impact factor: 3.386
Authors: Dorothea D Jenkins; Laura Grace Rollins; Jessica K Perkel; Carol L Wagner; Lakshmi P Katikaneni; W Thomas Bass; David A Kaufman; Michael J Horgan; Sheela Languani; Lawrence Givelichian; Koravangattu Sankaran; Jerome Y Yager; Renee H Martin Journal: J Cereb Blood Flow Metab Date: 2012-07-18 Impact factor: 6.200
Authors: Michael Frink; Sascha Flohé; Martijn van Griensven; Philipp Mommsen; Frank Hildebrand Journal: Mediators Inflamm Date: 2012-03-13 Impact factor: 4.711